Ratcliffe Liam bought OKUR
March 31, 2026 · Form 4 insider transaction
Ratcliffe Liam bought 15,300 shares of OnKure Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,300
Price
$0.00
Total value
N/A
InsiderRatcliffe Liam
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after15,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/36th of the shares subject to the option shall vest on April 30, 2026 and on the last day of each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.